AGAP2 Antibody

Product: FRAX487

AGAP2 Antibody Summary

Immunogen
Recombinant human AGAP2 / PIKE.
Specificity
Amino acids 1-836 of human AGAP2 protein.
Clonality
Polyclonal
Host
Rabbit
Gene
AGAP2
Purity
Protein A purified
Innovators Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Learn about the Innovators Reward

Applications/Dilutions

Dilutions
  • Western Blot 1:5000-1:20000
  • ELISA 1:40000-1:200000
  • Immunocytochemistry/Immunofluorescence 1:10-1:500
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Paraffin 5 ug/ml

Packaging, Storage & Formulations

Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Buffer
PBS (pH 7.2)
Preservative
0.01% Sodium Azide
Concentration
1.0 mg/ml
Purity
Protein A purified

Alternate Names for AGAP2 Antibody

  • AGAP-2
  • ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
  • arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2
  • centaurin, gamma 1
  • centaurin-gamma-1
  • CENTG1
  • cnt-g1
  • FLJ16430
  • GGAP2
  • GTP-binding and GTPase activating protein 2
  • GTP-binding and GTPase-activating protein 2
  • KIAA0167
  • Phosphatidylinositol-3-kinase enhancer
  • phosphoinositide 3-kinase enhancer
  • PIKEArf GAP with GTP-binding protein-like, ANK repeat and PH domains 2

Background

AGAP2 (also known as centaurin-gamma1, ARF-GAP with GTP-binding protein-like, ankyrin repeat and pleckstrin homology domains 2, Phosphatidyl-inositol-3-kinase enhancer, PIKE, GTP-binding and GTPase activating protein 2 and GGAP2) is a GTPase activating protein that inactivates Arf. The expression of AGAP2 is amplified in human glioblastoma cells. AGAP2 protein binds to and activates the protein kinase Akt and prevents apoptosis of cancer cells. AGAP2 also increases motility and invasive activity of cancer cells. AGAP2 may serve as a diagnostic and therapeutic target of human cancer.

PMID: 22370157

AGAP2 Antibody

Product: Chlorpromazine (D8 hydrochloride)

AGAP2 Antibody Summary

Immunogen
Antibody was raised against a peptide corresponding to 15 amino acids near the C-terminus of human PIKE. The immunogen is located within the last 50 amino acids of PIKE.
Specificity
Anti-PIKE will detect both PIKE-L and PIKE-A isoforms.
Clonality
Polyclonal
Host
Rabbit
Gene
AGAP2
Purity
Ion exchange chromatography
Innovators Reward
Test in a species/application not listed above to receive a full credit towards a future purchase.

Learn about the Innovators Reward

Applications/Dilutions

Dilutions
  • Western Blot 1:100-1:2000
  • ELISA 1:100-1:2000
  • Immunohistochemistry 1:10-1:500
  • Immunohistochemistry-Paraffin 1:10-1:500
Application Notes
PIKE antibody can be used for detection of PIKE by Western blot at 0.5 to 1 mg/ml. Anti-PIKE will detect both PIKE-L and PIKE-A isoforms.
Control Peptide
AGAP2 Peptide (NBP1-77194PEP)

Packaging, Storage & Formulations

Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Buffer
PBS
Preservative
0.02% Sodium Azide
Concentration
1 mg/ml
Purity
Ion exchange chromatography

Alternate Names for AGAP2 Antibody

  • AGAP-2
  • ArfGAP with GTPase domain, ankyrin repeat and PH domain 2
  • arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2
  • centaurin, gamma 1
  • centaurin-gamma-1
  • CENTG1
  • cnt-g1
  • FLJ16430
  • GGAP2
  • GTP-binding and GTPase activating protein 2
  • GTP-binding and GTPase-activating protein 2
  • KIAA0167
  • Phosphatidylinositol-3-kinase enhancer
  • phosphoinositide 3-kinase enhancer
  • PIKEArf GAP with GTP-binding protein-like, ANK repeat and PH domains 2

Background

Phosphoinositide 3 kinase enhancer (PIKE) is a recently identified nuclear GTPase that interacts with nuclear phosphoinositide 3-kinase (PI3 kinase) to stimulate its lipid kinase activity. PIKE exists in multiple isoforms; a shorter C-terminal isoform (PIKE-A) has also been identified as centaurin gamma 1. The longest isoform (PIKE-L) has been shown to bind to the adaptor protein Homer and thereby link to metabotropic glutamate receptors, leading to activation of PI3 kinase activity and prevention of neuronal apoptosis. Overexpression of PIKE-A enhances Akt activity and promotes cancer cell invasion, whereas decreased expression of PIKE-A via dominant negative expression of PIKE-A or PIKE-A knockdown inhibits these processes. In many human cancers, expression of PIKE-A is enhanced, leading to increased Akt activity and preventing apoptosis.

PMID: 20085656